Market Overview
The global myeloproliferative disorder treatment market was valued at USD 9.20 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.6% during the forecast period. Myeloproliferative disorders (MPDs) are a group of hematologic diseases characterized by the excessive production of blood cells in the bone marrow. These disorders can lead...